EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hepatitis C virus infects and perturbs liver stem cells

Nathan L Meyers, Tal Ashuach, Danielle E Lyons, Mir M Khalid iD, Camille R Simoneau, Ann L Erickson, Mehdi Bouhaddou, Thong T Nguyen, G Renuka Kumar, Taha Y Taha, Vaishaali Natarajan, Jody L Baron und 9 weitere

mBio · 19.12.2023 · 14 (6)

DOI: 10.1128/mbio.01318-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, erschienen am 19.12.2023. Verfasst von Nathan L Meyers und 20 weiteren Autor:innen. Beteiligte Einrichtung: Gladstone Institute of Virology, San Francisco, California, USA. Hauptthemen laut MEDLINE: Hepacivirus, Organoids, Liver, Hepatitis C. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIAID NIH HHS, Division of Intramural Research, National Institute of Allergy and Infectious Diseases (DIR, NIAID).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis C virus (HCV) is the leading cause of death from liver disease. How HCV infection causes lasting liver damage and increases cancer risk remains unclear. Here, we identify bipotent liver stem cells as novel targets for HCV infection, and their erroneous differentiation as the potential cause of impaired liver regeneration and cancer development. We show 3D organoids generated from liver stem cells from actively HCV-infected individuals carry replicating virus and maintain low-grade infection over months. Organoids can be infected with a primary HCV isolate. Virus-inclusive single-cell RNA sequencing uncovered transcriptional reprogramming in HCV + cells supporting hepatocytic differentiation, cancer stem cell development, and viral replication while stem cell proliferation and interferon signaling are disrupted. Our data add a new pathogenesis mechanism—infection of liver stem cells—to the biology of HCV infection that may explain progressive liver damage and enhanced cancer risk through an altered stem cell state. IMPORTANCE The hepatitis C virus (HCV) causes liver disease, affecting millions. Even though we have effective antivirals that cure HCV, they cannot stop terminal liver disease. We used an adult stem cell-derived liver organoid system to understand how HCV infection leads to the progression of terminal liver disease. Here, we show that HCV maintains low-grade infections in liver organoids for the first time. HCV infection in liver organoids leads to transcriptional reprogramming causing cancer cell development and altered immune response. Our finding shows how HCV infection in liver organoids mimics HCV infection and patient pathogenesis. These results reveal that HCV infection in liver organoids contributes to liver disease progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepacivirusOrganoidsLiverHepatitis CHumansStem CellsAnimalsHepatocytesMice

Stichwörter der Autor:innen

chronic infectionhepatitis c virushepatocellular carcinomaliver diseaseorganoidsingle-cell RNA sequencingstem cell

Autor:innen und Institutionen

  • Gladstone Institute of Virology, San Francisco, California, USA.
  • Department of Electrical Engineering and Computer Science and Center for Computational Biology, University of California Berkeley, Berkeley, California, USA.
  • California Pacific Medical Center Research Institute, San Francisco, California, USA.
  • Cellular and Molecular Pharmacology, University of California, San Francisco, California, USA.
  • Gladstone Institute of Data Science and Biotechnology, San Francisco, California, USA.
  • Quantitative Biosciences Institute, University of California, San Francisco, California, USA.

ORCID-Profile: Mir M Khalid, Tokameh Mahmoudi, Nir Yosef, Melanie Ott

Förderung

  • NIDDK NIH HHS
  • NIAID NIH HHS
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases (DIR, NIAID)
  • Chan Zuckerberg Initiative (CZI)
  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Meyers, N. L., Ashuach, T., Lyons, D. E., Khalid, M. M., Simoneau, C. R., Erickson, A. L., Bouhaddou, M., Nguyen, T. T., Kumar, G. R., Taha, T. Y., Natarajan, V., Baron, J. L., Neff, N., Zanini, F., Mahmoudi, T., Quake, S. R., Krogan, N. J., Cooper, S., McDevitt, T. C., …, & Ott, M. (2023). Hepatitis C virus infects and perturbs liver stem cells. mBio, 14(6). https://doi.org/10.1128/mbio.01318-23

Vancouver

Meyers NL, Ashuach T, Lyons DE, Khalid MM, Simoneau CR, Erickson AL, et al. Hepatitis C virus infects and perturbs liver stem cells. mBio. 2023;14(6). doi:10.1128/mbio.01318-23

BibTeX
@article{Meyers2023,
  author = {Meyers, Nathan L and Ashuach, Tal and Lyons, Danielle E and Khalid, Mir M and Simoneau, Camille R and Erickson, Ann L and Bouhaddou, Mehdi and Nguyen, Thong T and Kumar, G Renuka and Taha, Taha Y and Natarajan, Vaishaali and Baron, Jody L and Neff, Norma and Zanini, Fabio and Mahmoudi, Tokameh and Quake, Stephen R and Krogan, Nevan J and Cooper, Stewart and McDevitt, Todd C and Yosef, Nir and Ott, Melanie},
  title = {Hepatitis C virus infects and perturbs liver stem cells},
  journal = {mBio},
  year = {2023},
  volume = {14},
  number = {6},
  doi = {10.1128/mbio.01318-23}
}
Kostenlos starten →